Salvianolic Acid B Inhibits ZBP1 ‐Mediated PANoptosis in Mycobacterium tuberculosis ‐Infected Macrophages by Targeting TNFR1
Phytotherapy Research · 2025-09 · 39 (9) · 4028-4045
DOI: 10.1002/ptr.70042 ↗At a glance
Journal article in Phytotherapy Research, published online on 2025-07-27. Written by Jingjing Shen and 7 co-authors. Institution: Department of Immunology and Pathogenic Biology, Center for Traditional Chinese Medicine and Immunology Research, School of Integrative Medicine, Sha…. Major MEDLINE topics: Mycobacterium tuberculosis, Benzofurans, Macrophages, Receptors, Tumor Necrosis Factor, Type I. Cited 11 times so far (Crossref); 64 references. Funded by: National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project.
Abstract (original language)
The increasing rates of drug resistance in Mycobacterium tuberculosis (Mtb) have made controlling tuberculosis more challenging. Excessive programmed cell death helps mediate Mtb transmission. Salvianolic acid B (Sal B), a water‐soluble extract of Salvia miltiorrhiza , has been reported to inhibit programmed cell death and excessive inflammation. This study aimed to investigate the potential inhibitory mechanism of Sal B on PANoptosis. The inhibitory effect of Sal B on PANoptosis was evaluated by western blotting, ELISA, and other techniques in an in vitro model of Mtb H37Ra‐infected macrophages. The roles of ZBP1 and TNFR1 in PANoptosis were explored by small interfering RNA transfection. In addition, the inhibitory effect of Sal B on PANoptosis and the hyperinflammatory response was verified by western blotting, hematoxylin and eosin staining, and immunohistochemistry in an in vivo model of inflammatory injury in the lungs of LPS‐infected mice. Sal B inhibited the protein levels of key molecules of Mtb‐mediated PANoptosis and hindered the assembly of the PANoptosome consisting of ASC, ZBP1, RIPK1, RIPK3, and Caspase 8. Sal B may further inhibit PANoptosis by binding to TNFR1 and suppressing ZBP1 levels. In addition, the results of in vivo studies verified that Sal B could ameliorate LPS‐induced pathological injury in mouse lung tissues. Sal B can target TNFR1 to achieve a regulatory effect on macrophage PANoptosis. This provides new ideas for Sal B as a host‐directed therapy drug to attenuate the excessive inflammatory response induced by Mtb infection.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Immunology and Pathogenic Biology, Center for Traditional Chinese Medicine and Immunology Research, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Infectious Diseases, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
ORCID profiles: Jingjing Shen
Funding
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
Cite
APA
Shen, J., Fu, Y., Liu, F., Wu, J., Zhang, H., Sun, J., Miao, Z., & Jiang, X. (2025). Salvianolic Acid B Inhibits ZBP1 ‐Mediated PANoptosis in Mycobacterium tuberculosis ‐Infected Macrophages by Targeting TNFR1. Phytotherapy Research, 39(9), 4028-4045. https://doi.org/10.1002/ptr.70042
Vancouver
Shen J, Fu Y, Liu F, Wu J, Zhang H, Sun J, et al. Salvianolic Acid B Inhibits ZBP1 ‐Mediated PANoptosis in Mycobacterium tuberculosis ‐Infected Macrophages by Targeting TNFR1. Phytotherapy Research. 2025;39(9):4028-4045. doi:10.1002/ptr.70042
BibTeX
@article{Shen2025,
author = {Shen, Jingjing and Fu, Yan and Liu, Fanglin and Wu, Jianchao and Zhang, Hemin and Sun, Jinxia and Miao, Zhulei and Jiang, Xin},
title = {Salvianolic Acid B Inhibits ZBP1 ‐Mediated PANoptosis in Mycobacterium tuberculosis ‐Infected Macrophages by Targeting TNFR1},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {9},
pages = {4028--4045},
doi = {10.1002/ptr.70042}
}
EUVIMED